Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Darracott Vaughan

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
American Journal of Hypertension|August 9, 2014
Curable renal hypertension: renin, marker or cause? Question answeredE Darracott Vaughan
The Medical Clinics of North America|March 31, 2004
Diseases of the adrenal glandE Darracott Vaughan
The New England Journal of Medicine|December 19, 2003
Medical management of benign prostatic hyperplasia--are two drugs better than one?E Darracott Vaughan
Thescientificworldjournal|September 7, 2004
Surgery of the adrenalsE Darracott Vaughan
Reviews in Urology|September 21, 2006
Long-Term Experience with 5-alpha-Reductase InhibitorsE Darracott Vaughan
Urology|March 4, 2015
Editorial commentE Darracott Vaughan
Reviews in Urology|September 21, 2006
Long-Term Experience With 5-alpha-Reductase InhibitorsE Darracott Vaughan
The Canadian Journal of Urology|April 15, 2009
Legends in urologyE Darracott Vaughan
Drugs & Aging|December 6, 2005
Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment optionsJaspreet S Sandhu, E Darracott Vaughan
The Journal of Urology|November 13, 2004
Jay Y. GillenwaterStuart S Howards, E Darracott Vaughan
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
American Journal of Hypertension|August 9, 2014
Curable renal hypertension: renin, marker or cause? Question answeredE Darracott Vaughan
The Medical Clinics of North America|March 31, 2004
Diseases of the adrenal glandE Darracott Vaughan
The New England Journal of Medicine|December 19, 2003
Medical management of benign prostatic hyperplasia--are two drugs better than one?E Darracott Vaughan
Thescientificworldjournal|September 7, 2004
Surgery of the adrenalsE Darracott Vaughan
Reviews in Urology|September 21, 2006
Long-Term Experience with 5-alpha-Reductase InhibitorsE Darracott Vaughan
Urology|March 4, 2015
Editorial commentE Darracott Vaughan
Reviews in Urology|September 21, 2006
Long-Term Experience With 5-alpha-Reductase InhibitorsE Darracott Vaughan
The Canadian Journal of Urology|April 15, 2009
Legends in urologyE Darracott Vaughan
Drugs & Aging|December 6, 2005
Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment optionsJaspreet S Sandhu, E Darracott Vaughan
The Journal of Urology|November 13, 2004
Jay Y. GillenwaterStuart S Howards, E Darracott Vaughan
Pageof 5